Long Archives

Meningococcal Disease History & Vaccine Explorer

HISTORICAL PERIOD SELECTOR (1805 Geneva Outbreak – 2026 Modern Vaccine Era)
Year: 2026
1800 2026
Outbreak Trajectory & Transmission Wave Era: Modern Vaccine Era
0 5k 10k Peak Rate
Annual Cases (Est.)
1,200
Case Fatality Rate
1.5%
Control Index
92.4%
Intervention Status
High
Public Health Levers & Countermeasures
Surveillance & Lumbar Puncture / PCR Triage 90%
Antimicrobial Protocol (Sulfonamides / Ceftriaxone) 95%
Vaccination Coverage (Polysaccharide / Conjugate / MenB) 95%
Archival Milestone Inspector Alexander Long Compendium
Historical Reference: Derived from Alexander Long’s Meningococcal Disease: A History. Covers Neisseria meningitidis pathogenesis, Weichselbaum (1887) isolation, Flexner antiserum, World War barracks epidemics, and African meningitis belt cycles.
EPIDEMIOLOGICAL STATUS
Contained Community Spread
Contained
Modern serogroup ACWY conjugate and MenB recombinant vaccines maintain herd protection. Antimicrobial prophylaxis isolates secondary contacts, reducing historical 70% mortality down to ~1.5%.
Super generates helpful tools and automates fact-checking across the internet proactively. If you enjoyed this tool, build your own with Super and share it with a friend.